RA Capital Management’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$156M	Hold	11,189,693	–	–	1.65%	15
2025 Q4	$154M	Hold	11,189,693	–	–	1.58%	15
2025 Q3	$273M	Hold	11,189,693	–	–	3.37%	10
2025 Q2	$258M	Hold	11,189,693	–	–	4.35%	4
2025 Q1	$302M	Buy	11,189,693 +824,041	+8%	+$31.1M	5.05%	4
2024 Q4	$555M	Buy	10,365,652 +1,200,000	+13%	+$63.5M	7.39%	3
2024 Q3	$416M	Hold	9,165,652	–	–	4.8%	3
2024 Q2	$384M	Hold	9,165,652	–	–	5.08%	3
2024 Q1	$345M	Hold	9,165,652	–	–	4.39%	4
2023 Q4	$98.3M	Hold	9,165,652	–	–	1.54%	16
2023 Q3	$92.4M	Buy	9,165,652 +495,008	+6%	+$5.71M	1.82%	15
2023 Q2	$103M	Hold	8,670,644	–	–	1.94%	13
2023 Q1	$105M	Hold	8,670,644	–	–	2.38%	12
2022 Q4	$114M	Hold	8,670,644	–	–	2.32%	14
2022 Q3	$117M	Hold	8,670,644	–	–	2.5%	10
2022 Q2	$106M	Hold	8,670,644	–	–	2.82%	7
2022 Q1	$124M	Hold	8,670,644	–	–	2.71%	7
2021 Q4	$171M	Hold	8,670,644	–	–	3.02%	5
2021 Q3	$188M	Hold	8,670,644	–	–	2.6%	8
2021 Q2	$216M	Buy	+8,670,644	New	+$193M	3.47%	4